Recap of the Zoom-In Webinar: Life Science Panel
NAIOP SFBA’s March 25th Zoom-in webinar explored the hot Bay Area Life Sciences Market with a panel of leading experts. Moderated by veteran broker Ben Paul, Executive Managing Director/Principal, Cushman & Wakefield, the discussion focused on the needs and wants of today's tenants, as well as the challenges and opportunities that this dynamic market presents.
Panelists included:
Allison Hoffmann,Principal, T3 Advisors
Tara Korlipara, Vice President, Blue Rise Ventures
Rebekah Studer, Leasing Manager, Phase3 Real Estate Partners
Here is a brief recap of key points:
Market Overview
The size of the national life science market is only about 200M square feet which is relatively small given all the press it is getting. The broader healthcare market was outpacing growth in many of the other sectors even before Covid.
The Bay Area has about 30M square feet and there is about 40M in Cambridge and about 20M in San Diego. The Bay Area’s 30M sf consists of the 9M in the East Bay and 1M under construction. Peninsula has 20-25M with 4M under construction and 1M available.
In terms of demand, the East Bay is running at about 500K – 1M sf (included all lab and food tech users), on the Peninsula there is about 3M sf of demand. Both markets had great absorption in 2020 and current demand is greater than it was pre-Covid. After being relatively non-existent in 2015-16, the venture capital and IPO market broke loose in 2017 causing an explosion in demand.
Q - What is your view on the state of the market?
Studer
- Market has maintained bullish state / their conviction and that of their capital partners remains strong
- There has been a bigger magnifying glass on the market worldwide
- Has sparked a lot of interest from investors and the NIH
- Groups are pivoting their science / starting new sciences
- The evolution is driving demand for this type of real estate
- Rents and costs are being driven up
- Tenants need expertise to help navigate planning and building out suitable spaces
Korlipara
- Signed 20 leases in Alameda from 5k – 120k sf / total of 400k sf since Covid started
- Continuing to do multiple tours per week
- Tenants who occupied a year ago already asking for expansion opportunities
- Their team has done a really good job of listening to tenants and creating a life science ecosystem for them
- In North San Jose attracting biotech interests as well as more traditional users / renewal energy and mobility tech
Hoffmann
- Setting expectations is the hardest part / some tenants think Covid drove rates down
- $16.8 B was spent in venture capital in 2020 on the industry
- Money pumped in for growth, expansion and manufacturing
- Increasing competition / lack of availability especially for space in 10k – 30k sf range
- Unfortunately fundraising needs to align with lease execution and is often too late
- Advises clients to start looking for space the second they have an idea about their growth / ideally a year out – can work with 9 months
- The shorter the timeframe gets the more they rely on developers building spec space such as Phase3
Q - How do you capture the demand in the spec market?
Studer
- Over the years doing conversions they have been able to pick and choose which features tenants need
- If tenants want flexibility it’s a really big dollar sign
- Smaller tenants focused on more science and have less admin staff
- Larger companies are farther along in process and need more office / less lab space
- Spec builds are a trigger for companies that need space in next 30 – 60 days
- Quickest deal to date - lease signed in 2 weeks / space was available and ready to go
Korlipara
- First tenant large company to sign in Alameda helped get them some traction with other tenants
- Finding ways to fulfill their needs
- Got a contract vivarium company which is an amenity for small tenants
- Added an amenity center with fitness center and conference space
Q - How do you see tenants valuing amenities?
Hoffmann
- Thinks the trend is here to stay
- Sees space becoming more similar to the tech style
- Once you tour them through they understand the difference in rates
Studer
- Real estate is huge for talent attraction
- For example, Genesis Marina
- Right on the water front
- Views
- Bay trail with 500 miles of biking
- Great fitness center
Korlipara
- In Alameda they have an amenities center
- Conference spaces
- Food
- Fitness Center
- Thinks Alameda itself is an amenity
- Parking
- Walking path
- Yacht club with kayaks and bikes
- Programs such as Weds breakfast / Happy Hours
Q – Tell us about a newly funded company and how quickly they have grown.
Hoffmann
- Allakos – started out with ten employees a few years ago / now projected to have over 200.
- Put them in first space 5-6k sf
- Within 18 months moved them into 25k sf
- Now 18 months into their lease moving them into 100K sf space
- The more funding these companies get the more money they have to support their clinical milestones
- With each clinical milestone comes a different aspects of the business they need to grow
Q - Are you seeing companies doing cell gene therapy locally as opposed to internationally and looking for CGMP space (FDA regulated “Current Good Manufacturing Practice”)?
Hoffmann
- Helps companies look at the best option in terms of cost, talent and proximity to their headquarters
- Has a mixed response
- Many groups want to stay local
- Locating it in East Bay where rates are cheaper
- Looking for industrial buildings that can easily be programed for these types of manufacturing spaces
Korlipara
- Has tenants putting in small scale CGMP space / pilot plants
- Cell and gene therapy and food tech tenants
- Thinks it’s an exciting thing to get involved with
Q – Tell us about the conversion of 1900 Alameda de las Pulgas.
Studer
- First lab space in the City of San Mateo
- C-suite execs that live in San Mateo are drawn to it as they can bike to work
- It’s a central point of access for getting to South SF and Palo Alto
- Identified it as a six tenant building / Four smaller and two larger suites
- Leased two of the smaller suites at the beginning of this year
- Recently got TCO on top two floors
- Seeing a lot of tour activity
Q - What are the key elements to converting an office building to life science use? How do you justify spending all that money with start-up companies?
Paul
- Lab space is very predictable and reusable
- Underwriting the repurposing of lab space at lower costs than office space
- Tenants in 5k – 100k sf range need 45-50% office/lab ratio
Often a portion is biology lab / smaller portion chem lab and vivarium space
- Capital markets are valuing the income without a big spread in the cap rates from start-ups to mature companies
- Phase3’s Genesis Towers Project in So SF is a great example
- It’s both a conversion and a spec deal
- They built a new building as well
- High level of amenities
- Not a single credit tenant
- Exited it at a massive number and low cap rate (4.7)
Q - Do tenants look at conversions differently than purpose built new construction?
Hoffmann
- At the end of the day they just want a space that works for them and for their science
- Given the tight market and if clients are financially able, advises clients to take on additional space if it makes sense, and sublease it
Q – What are you seeing in terms of diversity of demand?
Hoffmann
- Focuses on biotech and med device seeing increased competition
- Auto tech groups
- Has a semiconductor client competing as well (has similar need for dry labs)
Korlipara
- In North San Jose, BioCube is bring biotech tenants to the campus
- Started to build out spec suites
- Seeing interest from renewable energy tenants
- Closer to needs of biotech companies
- Base building infrastructure is similar enough to pivot